EUVIMEDEUVIMED entdecken
Crossref

Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity In Vitro and In Vivo against Methicillin-Resistant Staphylococcus aureus

Seoung-Ryoung Choi iD, Geoffrey A Talmon, Kenneth Hearne, Jennifer Woo, Vu L Truong, Bradley E Britigan, Prabagaran Narayanasamy iD

Molecular Pharmaceutics · 07.08.2023 · 20 (8) · 4058-4070

DOI: 10.1021/acs.molpharmaceut.3c00223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 20.07.2023. Verfasst von Seoung-Ryoung Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Gallium. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: State of Nebraska.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a major need for the development of new therapeutics to combat antibiotic-resistant Staphylococcus aureus. Recently, gallium (Ga)-based complexes have shown promising antimicrobial effects against various bacteria, including multidrug-resistant organisms, by targeting multiple heme/iron-dependent metabolic pathways. Among these, Ga protoporphyrin (GaPP) inhibits bacterial growth by targeting heme pathways, including aerobic respiration. Ga(NO3)3, an iron mimetic, disrupts elemental iron pathways. Here, we demonstrate the enhanced antimicrobial activity of the combination of GaPP and Ga(NO3)3 against methicillin-resistant S. aureus (MRSA) under iron-limited conditions, including small colony variants (SCV). This therapy demonstrated significant antimicrobial activity without inducing slow-growing SCV. We also observed that the combination of GaPP and Ga(NO3)3 inhibited the MRSA catalase but not above that seen with Ga(NO3)3 alone. Neither GaPP nor Ga(NO3)3 alone or their combination inhibited the dominant superoxide dismutase expressed (SodA) under the iron-limited conditions examined. Intranasal administration of the combination of the two compounds improved drug biodistribution in the lungs compared to intraperitoneal administration. In a murine MRSA lung infection model, we observed a significant increase in survival and decrease in MRSA lung CFUs in mice that received combination therapy with intranasal GaPP and Ga(NO3)3 compared to untreated control or mice receiving GaPP or Ga(NO3)3 alone. No drug-related toxicity was observed as assessed histologically in the spleen, lung, nasal cavity, and kidney for both single and repeated doses of 10 mg Ga /Kg of mice over 13 days. Our results strongly suggest that GaPP and Ga(NO3)3 in combination have excellent synergism and potential to be developed as a novel therapy for infections with S. aureus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusGalliumAnimalsMiceProtoporphyrinsStaphylococcus aureusTissue DistributionAnti-Bacterial AgentsHemeIronMicrobial Sensitivity Tests

Stichwörter der Autor:innen

MRSAcombinationgalliummicesmall colony varianttoxicity

Substanzen

Protoporphyrinsgallium nitrateAnti-Bacterial AgentsGalliumHemeIron

Autor:innen und Institutionen

  • Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Aridis Pharmaceuticals, Los Gatos, California 95032, United States.
  • Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Department of Internal Medicine and Research Service, Veterans Affairs Medical Center-Nebraska Western Iowa, Omaha, Nebraska 68105, United States.

ORCID-Profile: Seoung-Ryoung Choi, Prabagaran Narayanasamy

Förderung

  • State of Nebraska

Zitieren

APA

Choi, S. R., Talmon, G. A., Hearne, K., Woo, J., Truong, V. L., Britigan, B. E., & Narayanasamy, P. (2023). Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity In Vitro and In Vivo against Methicillin-Resistant Staphylococcus aureus. Molecular Pharmaceutics, 20(8), 4058-4070. https://doi.org/10.1021/acs.molpharmaceut.3c00223

Vancouver

Choi SR, Talmon GA, Hearne K, Woo J, Truong VL, Britigan BE, et al. Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity In Vitro and In Vivo against Methicillin-Resistant Staphylococcus aureus. Molecular Pharmaceutics. 2023;20(8):4058-4070. doi:10.1021/acs.molpharmaceut.3c00223

BibTeX
@article{Choi2023,
  author = {Choi, Seoung-Ryoung and Talmon, Geoffrey A and Hearne, Kenneth and Woo, Jennifer and Truong, Vu L and Britigan, Bradley E and Narayanasamy, Prabagaran},
  title = {Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity In Vitro and In Vivo against Methicillin-Resistant Staphylococcus aureus},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {8},
  pages = {4058--4070},
  doi = {10.1021/acs.molpharmaceut.3c00223}
}
Kostenlos starten →